https://bsd.neuroinf.jp/w/index.php?action=history&feed=atom&title=%E3%83%86%E3%83%B3%E3%83%97%E3%83%AC%E3%83%BC%E3%83%88%3ANeuropeptidergics
テンプレート:Neuropeptidergics - 版の履歴
2026-05-04T19:23:44Z
このウィキのこのページに関する変更履歴
MediaWiki 1.43.8
https://bsd.neuroinf.jp/w/index.php?title=%E3%83%86%E3%83%B3%E3%83%97%E3%83%AC%E3%83%BC%E3%83%88:Neuropeptidergics&diff=31187&oldid=prev
WikiSysop: 1版
2015-08-05T10:16:25Z
<p>1版</p>
<p><b>新規ページ</b></p><div>{{Navbox<br />
| name = Neuropeptidergics<br />
| title = [[Neuropeptide]]rgics<br />
| state = {{{state<includeonly>|collapsed</includeonly>}}}<br />
| listclass = hlist<br />
<br />
| group1 = [[Calcitonin gene-related peptide receptor|CGRP]]<br />
| list1 =<br />
* '''Agonists:''' [[Amylin]]<br />
* [[Calcitonin gene-related peptide|CGRP]]<br />
* [[Pramlintide]]<br />
<br />
* '''Antagonists:''' [[BI 44370 TA]]<br />
* [[BMS-927711]]<br />
* [[CGRP (8-37)]]<br />
* [[MK-3207]]<br />
* [[Olcegepant]]<br />
* [[Rimegepant]]<br />
* [[SB-268262]]<br />
* [[Telcagepant]]<br />
* [[Ubrogepant]]<br />
<br />
| group2 = [[Cholecystokinin_receptor|Cholecystokinin]]<br />
| list2 = {{Navbox subgroup<br />
<br />
| group1 = [[Cholecystokinin A receptor|CCK<sub>A</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Cholecystokinin]]<br />
* [[CCK-4]]<br />
<br />
* '''Antagonists:''' [[Amiglumide]]<br />
* [[Asperlicin]]<br />
* [[Devazepide]]<br />
* [[Dexloxiglumide]]<br />
* [[Lintitript]]<br />
* [[Lorglumide]]<br />
* [[Loxiglumide]]<br />
* [[Pranazepide]]<br />
* [[Proglumide]]<br />
* [[Tarazepide]]<br />
* [[Tomoglumide]]<br />
<br />
| group2 = [[Cholecystokinin B receptor|CCK<sub>B</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Cholecystokinin]]<br />
* [[CCK-4]]<br />
* [[Gastrin]]<br />
<br />
* '''Antagonists:''' [[CI-988|CI-988 (PD-134,308)]]<br />
* [[Itriglumide]]<br />
* [[L-365,360]]<br />
* [[Netazepide]]<br />
* [[Proglumide]]<br />
* [[Spiroglumide]]<br />
<br />
}}<br />
<br />
| group3 = [[Corticotropin-releasing hormone receptor|CRH]]<br />
| list3 = {{Navbox subgroup<br />
<br />
| group1 = [[Corticotropin releasing hormone receptor 1|CRF<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Cortagine]]<br />
* [[Corticorelin]]<br />
* [[Corticotropin releasing hormone]]<br />
* [[Sauvagine]]<br />
* [[Stressin I]]<br />
* [[Urocortin]]<br />
<br />
* '''Antagonists:''' [[Antalarmin]]<br />
* [[Astressin-B]]<br />
* [[CP-154,526]]<br />
* [[Emicerfont]]<br />
* [[Hypericin]]<br />
* [[LWH-234]]<br />
* [[NBI-27914]]<br />
* [[Pexacerfont]]<br />
* [[R-121,919]]<br />
* [[TS-041]]<br />
* [[Verucerfont]]<br />
<br />
| group2 = [[Corticotropin releasing hormone receptor 2|CRF<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Corticorelin]]<br />
* [[Corticotropin releasing hormone]]<br />
* [[Sauvagine]]<br />
* [[Urocortin]]<br />
<br />
* '''Antagonists:''' [[Astressin-B]]<br />
<br />
}}<br />
<br />
| group4 = [[Galanin receptor|Galanin]]<br />
| list4 = {{Navbox subgroup<br />
<br />
| group1 = [[Galanin receptor 1|GAL<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Galanin]]<br />
* [[Galanin (1-15)]]<br />
* [[Galanin-like peptide]]<br />
* [[Galmic]]<br />
* [[Galnon]]<br />
<br />
* '''Antagonists:''' [[C7 (drug)|C7]]<br />
* [[Dithiepine-1,1,4,4-tetroxide]]<br />
* [[Galantide|Galantide (M15)]]<br />
* [[M32 (drug)|M32]]<br />
* [[M35 (drug)|M35]]<br />
* [[M40 (drug)|M40]]<br />
* [[SCH-202596]]<br />
<br />
| group2 = [[Galanin receptor 2|GAL<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Galanin]]<br />
* [[Galanin (1-15)]]<br />
* [[Galanin (2-11)]]<br />
* [[Galanin-like peptide]]<br />
* [[Galmic]]<br />
* [[Galnon]]<br />
* [[J18 (drug)|J18]]<br />
<br />
* '''Antagonists:''' [[C7 (drug)|C7]]<br />
* [[Galantide|Galantide (M15)]]<br />
* [[M32 (drug)|M32]]<br />
* [[M35 (drug)|M35]]<br />
* [[M40 (drug)|M40]]<br />
* [[M871 (drug)|M871]]<br />
<br />
| group3 = [[Galanin receptor 3|GAL<sub>3</sub>]]<br />
| list3 =<br />
* '''Agonists:''' [[Galanin]]<br />
* [[Galanin (1-15)]]<br />
* [[Galmic]]<br />
* [[Galnon]]<br />
<br />
* '''Antagonists:''' [[C7 (drug)|C7]]<br />
* [[Galantide|Galantide (M15)]]<br />
* [[GalR3ant]]<br />
* [[HT-2157]]<br />
* [[M32 (drug)|M32]]<br />
* [[M35 (drug)|M35]]<br />
* [[M40 (drug)|M40]]<br />
* [[SNAP-37889]]<br />
* [[SNAP-398299]]<br />
<br />
}}<br />
<br />
| group5 = [[Growth hormone secretagogue receptor|Ghrelin/GHS]]<br />
| list5 = <br />
* '''Agonists:''' [[Adenosine]]<br />
* [[Alexamorelin]]<br />
* [[Anamorelin]]<br />
* [[Capromorelin]]<br />
* [[CP-464709]]<br />
* [[Cortistatin-14]]<br />
* [[Examorelin|Examorelin (hexarelin)]]<br />
* [[Ghrelin|Ghrelin (lenomorelin)]]<br />
* [[GHRP-1]]<br />
* [[GHRP-3]]<br />
* [[GHRP-4]]<br />
* [[GHRP-5]]<br />
* [[GHRP-6]]<br />
* [[Ibutamoren|Ibutamoren (MK-677)]]<br />
* [[Ipamorelin]]<br />
* [[L-692,585]]<br />
* [[LY-426410]]<br />
* [[LY-444711]]<br />
* [[Macimorelin]]<br />
* [[Pralmorelin|Pralmorelin (GHRP-2)]]<br />
* [[Relamorelin]]<br />
* [[SM-130,686]]<br />
* [[Tabimorelin]]<br />
* [[Ulimorelin]]<br />
<br />
* '''Antagonists:''' [[A-778,193]]<br />
* [[Cortistatin-8]]<br />
* [[(D-Lys3)-GHRP-6|(<small>D</small>-Lys<sup>3</sub>)-GHRP-6]]<br />
* [[YIL-781]]<br />
<br />
| group6 = [[Melanin-concentrating hormone receptor|MCH]]<br />
| list6 = {{Navbox subgroup<br />
<br />
| group1 = [[Melanin-concentrating hormone receptor 1|MCH<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Melanin concentrating hormone]]<br />
<br />
* '''Antagonists:''' [[ATC-0065]]<br />
* [[ATC-0175]]<br />
* [[GW-803,430]]<br />
* [[NGD-4715]]<br />
* [[SNAP-7941]]<br />
* [[SNAP-94847]]<br />
<br />
| group2 = [[Melanin-concentrating hormone receptor 2|MCH<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Melanin concentrating hormone]]<!--<br />
<br />
* '''Antagonists:''' ..... --><br />
<br />
}}<br />
<br />
| group7 = [[Melanocortin receptor|Melanocortin]]<br />
| list7 = {{Navbox subgroup<br />
<br />
| group1 = [[Melanocortin 1 receptor|MC<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[α-MSH]]<br />
* [[β-MSH]]<br />
* [[γ-MSH]]<br />
* [[Adrenocorticotropic hormone|ACTH (corticotropin)]]<br />
* [[Afamelanotide]]<br />
* [[BMS-470,539]]<br />
* [[Bremelanotide]]<br />
* [[HS-014]]<br />
* [[HS-024]]<br />
* [[Melanotan II]]<br />
* [[Modimelanotide]]<br />
* [[PL-8177]]<br />
* [[SHU-8914]]<br />
* [[SHU-9005]]<br />
* [[SHU-9119]]<br />
* [[SNAP-7941]]<br />
<br />
* '''Antagonists:''' [[Agouti signalling peptide|ASIP]]<br />
<br />
| group2 = [[ACTH receptor|MC<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Adrenocorticotropic hormone|ACTH (corticotropin)]]<br />
* [[Alsactide]]<br />
* [[Codactide]]<br />
* [[Giractide]]<br />
* [[Norleusactide|Norleusactide (pentacosactride)]]<br />
* [[Seractide]]<br />
* [[Tetracosactide|Tetracosactide (tetracosactrin, cosyntropin)]]<br />
* [[Tosactide|Tosactide (octacosactrin)]]<br />
* [[Tricosactide]]<br />
* [[Tridecactide]]<!--<br />
<br />
* '''Antagonists:''' ..... --><br />
<br />
| group3 = [[Melanocortin 3 receptor|MC<sub>3</sub>]]<br />
| list3 =<br />
* '''Agonists:''' [[α-MSH]]<br />
* [[β-MSH]]<br />
* [[γ-MSH]]<br />
* [[Adrenocorticotropic hormone|ACTH (corticotropin)]]<br />
* [[Afamelanotide]]<br />
* [[Bremelanotide]]<br />
* [[Melanotan II]]<br />
* [[Modimelanotide]]<br />
* [[PG-931]]<br />
<br />
* '''Antagonists:''' [[Agouti-related peptide|AGRP]]<br />
* [[Agouti signalling peptide|ASIP]]<br />
* [[HS-014]]<br />
* [[ML-00253764]]<br />
* [[PG-106]]<br />
* [[SHU-8914]]<br />
* [[SHU-9005]]<br />
* [[SHU-9119]]<br />
<br />
| group4 = [[Melanocortin 4 receptor|MC<sub>4</sub>]]<br />
| list4 =<br />
* '''Agonists:''' [[α-MSH]]<br />
* [[β-MSH]]<br />
* [[γ-MSH]]<br />
* [[Adrenocorticotropic hormone|ACTH (corticotropin)]]<br />
* [[Afamelanotide]]<br />
* [[AZD2820]]<br />
* [[BIM-22493]]<br />
* [[Bremelanotide]]<br />
* [[LY-2112688]]<br />
* [[Melanotan II]]<br />
* [[MK-0493]]<br />
* [[Modimelanotide]]<br />
* [[PF-00446687]]<br />
* [[PG-931]]<br />
* [[PL-6983]]<br />
* [[Ro 27-3225]]<br />
* [[Setmelanotide]]<br />
* [[THIQ]]<br />
<br />
* '''Antagonists:''' [[Agouti-related peptide|AGRP]]<br />
* [[Agouti signalling peptide|ASIP]]<br />
* [[HS-014]]<br />
* [[HS-024]]<br />
* [[HS-131]]<br />
* [[JKC-363]]<br />
* [[MCL-0020]]<br />
* [[MCL-0042]]<br />
* [[MCL-0129]]<br />
* [[ML-00253764]]<br />
* [[MPB-10]]<br />
* [[SHU-8914]]<br />
* [[SHU-9005]]<br />
* [[SHU-9119]]<br />
<br />
* '''Unknown:''' [[Semax]]<br />
<br />
| group5 = [[Melanocortin 5 receptor|MC<sub>5</sub>]]<br />
| list5 =<br />
* '''Agonists:''' [[α-MSH]]<br />
* [[β-MSH]]<br />
* [[γ-MSH]]<br />
* [[Adrenocorticotropic hormone|ACTH (corticotropin)]]<br />
* [[Afamelanotide]]<br />
* [[Bremelanotide]]<br />
* [[HS-014]]<br />
* [[HS-024]]<br />
* [[Melanotan II]]<br />
* [[Modimelanotide]]<br />
* [[SHU-8914]]<br />
* [[SHU-9005]]<br />
* [[SHU-9119]]<br />
<br />
* '''Antagonists:''' [[Agouti signalling peptide|ASIP]]<br />
* [[ML-00253764]]<br />
<br />
* '''Unknown:''' [[Semax]]<br />
<br />
| group6 = Unsorted<br />
| list6 =<br />
* '''Agonists:''' [[Alsactide]]<br />
* [[Codactide]]<br />
* [[Giractide]]<br />
* [[Norleusactide|Norleusactide (pentacosactride)]]<br />
* [[Seractide]]<br />
* [[Tetracosactide|Tetracosactide (tetracosactrin, cosyntropin)]]<br />
* [[Tosactide|Tosactide (octacosactrin)]]<br />
* [[Tricosactide]]<br />
* [[Tridecactide]]<br />
<br />
}}<br />
<br />
| group8 = [[Neuropeptide S receptor|Neuropeptide S]]<br />
| list8 =<br />
* '''Agonists:''' [[Neuropeptide S]]<br />
<br />
* '''Antagonists:''' [[SHA-68]]<br />
<br />
| group9 = [[Neuropeptide Y receptor|Neuropeptide Y]]<br />
| list9 = {{Navbox subgroup<br />
<br />
| group1 = [[Neuropeptide Y receptor Y1|Y<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Neuropeptide Y]]<br />
* [[Peptide YY]]<br />
<br />
* '''Antagonists:''' [[BIBO-3304]]<br />
* [[BIBP-3226]]<br />
* [[BVD-10]]<br />
* [[GR-231,118]]<br />
* [[PD-160,170]]<br />
<br />
| group2 = [[Neuropeptide Y receptor Y2|Y<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[2-Thiouridine 5'-triphosphate]]<br />
* [[Neuropeptide Y]]<br />
* [[Neuropeptide Y (13-36)]]<br />
* [[Peptide YY]]<br />
* [[Peptide YY (3-36)]]<br />
<br />
* '''Antagonists:''' [[BIIE-0246]]<br />
* [[JNJ-5207787]]<br />
* [[SF-11]]<br />
<br />
| group3 = [[Pancreatic polypeptide receptor 1|Y<sub>4</sub>]]<br />
| list3 =<br />
* '''Agonists:''' [[GR-231,118]]<br />
* [[Neuropeptide Y]]<br />
* [[Pancreatic polypeptide]]<br />
* [[Peptide YY]]<br />
<br />
* '''Antagonists:''' [[UR-AK49]]<br />
<br />
| group4 = [[Neuropeptide Y receptor Y5|Y<sub>5</sub>]]<br />
| list4 =<br />
* '''Agonists:''' [[BWX-46]]<br />
* [[Neuropeptide Y]]<br />
* [[Peptide YY]]<br />
<br />
* '''Antagonists:''' [[CGP-71683]]<br />
* [[FMS-586]]<br />
* [[L-152,804]]<br />
* [[Lu AA-33810]]<br />
* [[MK-0557]]<br />
* [[NTNCB]]<br />
* [[Velneperit|Velneperit (S-2367)]]<br />
<br />
}}<br />
<br />
| group10 = [[Neurotensin receptor|Neurotensin]]<br />
| list10 = {{Navbox subgroup<br />
<br />
| group1 = [[Neurotensin receptor 1|NTS<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Neurotensin]]<br />
* [[Neuromedin N]]<br />
<br />
* '''Antagonists:''' [[Meclinertant]]<br />
* [[SR-142,948]]<br />
<br />
| group2 = [[Neurotensin receptor 2|NTS<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Neurotensin]]<br />
<br />
* '''Antagonists:''' [[Levocabastine]]<br />
* [[SR-142,948]]<br />
<br />
}}<br />
<br />
| group11 = [[Opioid receptor|Opioid]]<br />
| list11 = See [[Template:Opioidergics|here]] instead.<br />
<br />
| group12 = [[Orexin receptor|Orexin]]<br />
| list12 = {{Navbox subgroup<br />
<br />
| group1 = [[Hypocretin (orexin) receptor 1|OX<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Orexin-A]]<br />
* [[Orexin-B]]<br />
<br />
* '''Antagonists:''' [[ACT-335827]]<br />
* [[ACT-462206]]<br />
* [[Almorexant]]<br />
* [[Filorexant]]<br />
* [[Lemborexant]]<br />
* [[SB-334,867]]<br />
* [[SB-408,124]]<br />
* [[SB-649,868]]<br />
* [[Suvorexant]]<br />
* [[TCS-1102]]<br />
<br />
| group2 = [[Hypocretin (orexin) receptor 2|OX<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Orexin-A]]<br />
* [[Orexin-B]]<br />
* [[SB-668,875]]<br />
<br />
* '''Antagonists:''' [[ACT-335827]]<br />
* [[ACT-462206]]<br />
* [[Almorexant]]<br />
* [[EMPA (drug)|EMPA]]<br />
* [[Filorexant]]<br />
* [[JNJ-10397049]]<br />
* [[JNJ-42847922]]<br />
* [[Lemborexant]]<br />
* [[MK-1064]]<br />
* [[SB-649,868]]<br />
* [[Suvorexant]]<br />
* [[TCS-1102]]<br />
* [[TCS-OX2-29]]<br />
<br />
}}<br />
<br />
| group13 = [[Oxytocin receptor|Oxytocin]]<br />
| list13 =<br />
* '''Agonists:''' [[Aspartocin]]<br />
* [[Carbetocin]]<br />
* [[Cargutocin]]<br />
* [[Demoxytocin]]<br />
* [[Merotocin]]<br />
* [[Nacartocin]]<br />
* [[Oxytocin]]<br />
* [[TC OT 39]]<br />
* [[(Thr4, Gly7)-Oxytocin|TGOT]]<br />
* [[Vasotocin|Vasotocin (argiprestocin)]]<br />
* [[WAY-267,464]]<br />
<br />
* '''Antagonists:''' [[Atosiban]]<br />
* [[Barusiban]]<br />
* [[Epelsiban]]<br />
* [[Erlosiban]]<br />
* [[L-368,899]]<br />
* [[L-371,257]]<br />
* [[L-372,662]]<br />
* [[OBE001]]<br />
* [[Retosiban]]<br />
* [[SSR-126,768]]<br />
* [[Tocinoic acid]]<br />
* [[WAY-162,720]]<br />
<br />
| group14 = [[Tachykinin receptor|Tachykinin]]<br />
| list14 = {{Navbox subgroup<br />
<br />
| group1 = [[Tachykinin receptor 1|NK<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Substance P]]<br />
<br />
* '''Antagonists:''' [[Aprepitant]]<br />
* [[Befetupitant]]<br />
* [[Burapitant]]<br />
* [[Casopitant]]<br />
* [[CI-1021]]<br />
* [[CP-96,345]]<br />
* [[CP-99,994]]<br />
* [[CP-122,721]]<br />
* [[Dapitant]]<br />
* [[Ezlopitant]]<br />
* [[Figopitant]]<br />
* [[FK-888]]<br />
* [[Fosaprepitant]]<br />
* [[GR-203,040]]<br />
* [[GW-597,599]]<br />
* [[HSP-117]]<br />
* [[L-733,060]]<br />
* [[L-741,671]]<br />
* [[L-743,310]]<br />
* [[L-758,298]]<br />
* [[Lanepitant]]<br />
* [[LY-306,740]]<br />
* [[Maropitant]]<br />
* [[Netupitant]]<br />
* [[NKP-608]]<br />
* [[Nolpitantium besilate]]<br />
* [[Orvepitant]]<br />
* [[Rolapitant]]<br />
* [[RP-67,580]]<br />
* [[SDZ NKT 343]]<br />
* [[Serlopitant]]<br />
* [[Telmapitant]]<br />
* [[Tradipitant]]<br />
* [[Vestipitant]]<br />
* [[Vofopitant]]<br />
<br />
| group2 = [[Tachykinin receptor 2|NK<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Neurokinin A]]<br />
<br />
* '''Antagonists:''' [[GR-159,897]]<br />
* [[Ibodutant]]<br />
* [[Nepadutant]]<br />
* [[Saredutant]]<br />
<br />
| group3 = [[Tachykinin receptor 3|NK<sub>3</sub>]]<br />
| list3 =<br />
* '''Agonists:''' [[Neurokinin B]]<br />
<br />
* '''Antagonists:''' [[Osanetant]]<br />
* [[Talnetant]]<br />
<br />
}}<br />
<br />
| group15 = [[Vasopressin receptor|Vasopressin]]<br />
| list15 = {{Navbox subgroup<br />
<br />
| group1 = [[Arginine vasopressin receptor 1A|V<sub>1A</sub>]]<br />
| list1 =<br />
* '''Agonists:''' [[Felypressin]]<br />
* [[Lypressin]]<br />
* [[Ornipressin]]<br />
* [[Selepressin]]<br />
* [[Terlipressin]]<br />
* [[Vasopressin|Vasopressin (argipressin)]]<br />
* [[Vasotocin|Vasotocin (argiprestocin)]]<br />
<br />
* '''Antagonists:''' [[Atosiban]]<br />
* [[Conivaptan]]<br />
* [[FR-218944]]<br />
* [[JNJ-17079166]]<br />
* [[JNJ-17308616]]<br />
* [[LY-307174]]<br />
* [[PF-184563]]<br />
* [[Relcovaptan]]<br />
* [[RG7314]]<br />
* [[SRX246]]<br />
* [[SRX251]]<br />
* [[TC OT 39]]<br />
* [[WAY-267,464]]<br />
* [[YM-218]]<br />
* [[YM-471]]<br />
* [[YM-35471]]<br />
<br />
| group2 = [[Arginine vasopressin receptor 1B|V<sub>1B</sub>]]<br />
| list2 =<br />
* '''Agonists:''' [[Desmopressin]]<br />
* [[Felypressin]]<br />
* [[Lypressin]]<br />
* [[Ornipressin]]<br />
* [[Terlipressin]]<br />
* [[Vasopressin|Vasopressin (argipressin)]]<br />
* [[Vasotocin|Vasotocin (argiprestocin)]]<br />
<br />
* '''Antagonists:''' [[ABT-436]]<br />
* [[Nelivaptan]]<br />
* [[ORG-52186]]<br />
<br />
| group3 = [[Arginine vasopressin receptor 2|V<sub>2</sub>]]<br />
| list3 =<br />
* '''Agonists:''' [[Desmopressin]]<br />
* [[Felypressin]]<br />
* [[Lypressin]]<br />
* [[Ornipressin]]<br />
* [[TC OT 39]]<br />
* [[Terlipressin]]<br />
* [[Vasopressin|Vasopressin (argipressin)]]<br />
* [[Vasotocin|Vasotocin (argiprestocin)]]<br />
<br />
* '''Antagonists:''' [[Conivaptan]]<br />
* [[JNJ-17079166]]<br />
* [[Lixivaptan]]<br />
* [[Mozavaptan]]<br />
* [[RWJ-351647]]<br />
* [[Satavaptan]]<br />
* [[Tolvaptan]]<br />
* [[YM-471]]<br />
* [[YM-35471]]<br />
<br />
| group4 = Unsorted<br />
| list4 = <br />
* '''Antagonists:''' [[Ribuvaptan]]<br />
* [[RWJ-339489]]<br />
* [[VMAX-367]]<br />
* [[VMAX-372]]<br />
* [[VMAX-382]]<br />
* [[YM-222546]]<br />
<br />
}}<br />
<br />
<!--<br />
<br />
| group16 = [[Vasoactive intestinal peptide receptor|VIP]]<br />
| list16 = {{Navbox subgroup<br />
<br />
<br />
| group1 = [[VIPR1|VPAC<sub>1</sub>]]<br />
| list1 =<br />
* '''Agonists:''' .....<br />
<br />
* '''Antagonists:''' .....<br />
<br />
| group2 = [[VIPR2|VPAC<sub>2</sub>]]<br />
| list2 =<br />
* '''Agonists:''' .....<br />
<br />
* '''Antagonists:''' .....<br />
<br />
}}<br />
<br />
--><br />
<br />
| below = '''''See also:''' [[Template:Peptidergics|Peptidergics]]''<br />
<br />
}}<noinclude><br />
{{collapsible option}}<br />
[[Category:Drug templates by receptor, channel, or pump]]<br />
[[Category:Drugs by mechanism of action]]<br />
</noinclude></div>
WikiSysop